Atul Saran - Feb 23, 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Corp Dev, GC & Secretary
Signature
/s/ Scott Lieberman, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 23, 2022
Transactions value $
-$55,062
Form type
4
Date filed
2/25/2022, 04:19 PM
Previous filing
Feb 24, 2022
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$18.7K -442 -0.99% $42.23* 44.1K Feb 23, 2022 Direct F1
transaction EBS Common Stock Tax liability -$36.4K -857 -1.94% $42.47* 43.2K Feb 24, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.